Comparison of Two Therapeutic Strategies of Dermoval in Treatment of Bullous Pemphigus

Completed

• Conditions: Bullous Pemphigoid
• Interventions: Drug: Dermoval

• Registration Number: NCT00213421
• Lead Sponsor: University Hospital, Rouen

Brief Summary

to compare efficacity and tolerance of two stratégies of dermoval application in treatment of bullous pemphigus.

Detailed Description

Not available

Study Timeline

• Study Start: 2001-08
• Primary Completion: 2004-10
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-21
• Study Completion: 2008-11
• Status Verified: 2013-06
• Last Update Submitted: 2013-06-17
• Last Update Posted: 2013-06-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 330

Inclusion Criteria

• age > 18
• immunoflurescence, histological exam, predictive value according to bullous pemphigus diagnostic
• consentment patient

Exclusion Criteria

• age < 18
• no consentment
• localized bullous pemphigus (<400cm2)
• linear IgA pemphigus
• corticothérapy, immunotherapy
• pregnant woman pemphigus

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
1	Dermoval	-
2	Dermoval	-

Trial Locations

Locations (1)

UH-rouen; 🇫🇷 Rouen, Seine maritime, France